Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Programma di Terapia Per Pazienti Affetti da Linfoma Diffuso a Grandi Cellule B CD20 Positive

NCT00556127 is registered in ClinicalTrials.gov with Gruppo Italiano Multiregionale per lo studio dei Linfomi e delle Leucemie as lead sponsor.

NCT NCT00556127
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00556127 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Programma di Terapia Per Pazienti Affetti da Linfoma Diffuso a Grandi Cellule B CD20 Positive
Lead sponsor
Gruppo Italiano Multiregionale per lo studio dei Linfomi e delle Leucemie
Phase
Phase 2
Overall status
Completed
Start date
June 30, 2002
Completion date
September 30, 2006
Enrollment
94 (actual)
Sites
14

Conditions

As the registry lists them; a condition with its own page is linked.

diffuse large b-cell lymphoma, poor prognosis